Absci Ownership | Who Owns Absci?
Absci Ownership Summary
Absci is owned by 70.14% institutional investors, 9.25% insiders, and 20.60% retail investors. Fmr is the largest institutional shareholder, holding 11.89% of ABSI shares. ARK Genomic Revolution is the top mutual fund, with 8.20% of its assets in Absci shares.
ABSI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Absci | 70.14% | 9.25% | 20.60% |
| Sector | Healthcare Stocks | 479.67% | 11.03% | -390.70% |
| Industry | Biotech Stocks | 295.80% | 10.97% | -206.77% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 13.51M | 11.89% | $35.40M |
| Ark investment management | 10.05M | 7.87% | $25.82M |
| Blackrock funding, inc. /de | 8.36M | 6.55% | $21.49M |
| Redmile group | 8.25M | 6.47% | $21.21M |
| Blackrock | 5.34M | 5.38% | $16.46M |
| Vanguard group | 4.77M | 4.20% | $12.51M |
| Fred alger management | 3.93M | 3.08% | $10.10M |
| Ameriprise financial | 2.60M | 2.29% | $6.80M |
| State street | 2.02M | 1.78% | $5.29M |
| Massachusetts financial services co /ma/ | 2.23M | 1.75% | $5.72M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 8.25M | 2.26% | $21.21M |
| Casdin capital | 973.26K | 0.23% | $2.50M |
| Ark investment management | 10.05M | 0.19% | $25.82M |
| Pier 88 investment partners | 197.43K | 0.09% | $507.39K |
| Allen operations | 236.13K | 0.08% | $606.85K |
| Fred alger management | 3.93M | 0.05% | $10.10M |
| Institute for wealth management, llc. | 145.79K | 0.04% | $374.69K |
| Royce & associates lp | 1.52M | 0.04% | $3.90M |
| Nikko asset management americas | 1.45M | 0.04% | $3.71M |
| Iq eq fund management (ireland) | 158.30K | 0.04% | $406.83K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 5.34M | 0.00% | 4.45M |
| Blackrock funding, inc. /de | 8.36M | 0.00% | 1.58M |
| Fmr | 13.51M | 0.00% | 785.18K |
| Ubs group | 714.14K | 0.00% | 667.51K |
| Marshall wace, llp | 612.88K | 0.00% | 612.88K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Laurion capital management lp | - | - | -1.19M |
| Millennium management | 25.23K | - | -1.15M |
| Woodline partners lp | 1.05M | 0.02% | -1.04M |
| Affinity asset advisors | - | - | -1.02M |
| Merck | - | - | -998.16K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Graham capital management | 76.28K | 0.00% | 76.28K | $196.03K |
| Verition fund management | 46.03K | 0.00% | 46.03K | $118.30K |
| National bank of canada /fi/ | 34.50K | 0.00% | 34.50K | $88.67K |
| China universal asset management | 24.35K | 0.01% | 24.35K | $63.81K |
| Creative planning | 14.91K | - | 14.91K | $39.08K |
Sold Out
| Holder | Change |
|---|---|
| Pineridge advisors | -1.00 |
| Federated hermes | -3.00 |
| True wealth design | -9.00 |
| Capital performance advisors llp | -11.00 |
| Mendota financial group | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 134 | -8.22% | 89,499,197 | 4.64% | 70 | 1.49% | 72 | -14.29% | 34 | - |
| Mar 31, 2025 | 146 | 7.35% | 85,529,834 | 15.75% | 68 | 1.62% | 85 | 8.97% | 33 | 6.45% |
| Dec 31, 2024 | 134 | 5.51% | 73,861,284 | 2.04% | 65 | 1.60% | 76 | 18.75% | 31 | -8.82% |
| Sep 30, 2024 | 126 | 10.53% | 72,198,120 | 6.42% | 63 | 1.36% | 63 | -10.00% | 34 | 61.90% |
| Jun 30, 2024 | 113 | -5.04% | 67,844,007 | 12.16% | 68 | 1.60% | 70 | -15.66% | 21 | 50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Genomic Revolution | 10.44M | 8.20% | 2.48M |
| ARK Genomic Revolution ETF | 11.54M | 8.00% | -69.20K |
| Fidelity Growth Compy Commingled Pl S | 8.14M | 5.65% | 8.77K |
| Fidelity Growth Compy Commingled Pl O | 5.75M | 5.06% | - |
| Fidelity Growth Company Fund | 5.70M | 3.95% | - |
| Vanguard Total Stock Mkt Idx Inv | 4.08M | 2.73% | 34.84K |
| Alger Small Cap Focus Composite | 2.76M | 1.91% | - |
| Alger Small Cap Focus I | 2.76M | 1.91% | - |
| iShares Russell 2000 ETF | 2.55M | 1.77% | -48.51K |
| Columbia Acorn Inst | 2.02M | 1.40% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 28, 2025 | Busch Andreas | Chief Innovation Officer | Buy | $152.00K |
| Jun 13, 2024 | Jonasson Zachariah | CFO / CBO | Sell | $98.89K |
| May 22, 2024 | Phoenix Venture Partners II LP | - | Sell | $13.64M |
| Mar 01, 2024 | Redmile Group, LLC | - | Buy | $1000.00K |
| Feb 09, 2022 | Korman Sarah | General Counsel | Buy | $33.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | 1 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
ABSI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools